About: O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	O (nl) O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy (en)
skos:prefLabel	O (nl) O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy (en)
name	O (nl) O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy (en)
title	wds:Q65383396-8F774A48-8FDD-43BE-83CA-047E0C0BAE3A
title	A Phase 2 Study of O-Benzylguanine (O-BG) and Temozolomide in Patients With Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment With Radiation Therapy and Temozolomide (en)
end time	wds:Q65383396-420AD0CA-8ACE-4A06-87A2-F440667E44F0
end time	2010-03-15 00:00:00Z (xsd:dateTime)
instance of	wds:Q65383396-5C7F46AC-9D63-47D1-BDEA-6CE7BB3B73FF
instance of	clinical trial
start time	wds:Q65383396-576EF9A1-6438-4016-9558-C0022BB7E628
start time	2006-11-13 00:00:00Z (xsd:dateTime)
country	wds:Q65383396-2203FFC7-1BCB-44A9-9A3F-83E60CFBD62F
country	United States of America
main subject	wds:Q65383396-E82989F3-E507-417E-A254-AA0DF806F88F
main subject	recurrent adult brain tumor
research site	wds:Q65383396-198ED0F1-0E21-4FC9-92D8-A23AFFA0CD06
research site	National Institutes of Health
minimum age	wds:Q65383396-E3DCEF42-9829-4ED4-89BD-12B5AC65091F
minimum age	18 (xsd:decimal)
number of participants	wds:Q65383396-D0A639EC-25AB-442F-804A-5F2FAE94E25A
number of participants	12 (xsd:decimal)
maximum age	wds:Q65383396-09FE29E7-6494-4B73-AF82-5EF1EC99BC0B
maximum age	120 (xsd:decimal)
study type	wds:Q65383396-B8C45334-EA89-4FD1-A16F-12239CC5655E
study type	interventional study
ClinicalTrials.gov ID	wds:Q65383396-FF284361-CF8F-41B5-9AA2-75C1C687F585
ClinicalTrials.gov ID	NCT00436436
clinical trial phase	wds:Q65383396-3AF93429-9D05-4481-ADC0-A0AF344E3863
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65383396

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software